Home > Healthcare > Pharmaceuticals > Active Pharmaceutical Ingredients > U.S. Minor Cannabinoids Market

U.S. Minor Cannabinoids Market Share

Report ID: GMI10036
Published Date: Jun 2024
Report Format: PDF

Download Free Sample

U.S. Minor Cannabinoids Market Share

The competitive landscape of the U.S. minor cannabinoids industry is a dynamic and rapidly evolving, characterized by innovation and strategic partnerships. As awareness of the potential therapeutic benefits of minor cannabinoids continues to grow, an increasing number of companies are entering the market to capitalize on this burgeoning opportunity.

U.S. Minor Cannabinoids Market Companies

Prominent players operating in the U.S. minor cannabinoids industry include:

BayMedica (InMed Pharmaceuticals Inc.)
Fresh Bros Hemp Company
GVB Biopharma
GenCanna
KND Labs
Laurelcrest
Mile High Labs
Open Book Extracts
Rhizo Sciences
Verus Extracts
Viobin
ZERO POINT EXTRACTION, LLC

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

U.S. minor cannabinoids industry size was worth USD 278.2 million in 2023 and is projected to expand at 14.8% CAGR from 2024 to 2032, owing to the increasing consumer awareness and interest in the therapeutic benefits of minor cannabinoids.

The U.S. minor cannabinoids market share from the CBG type segment amassed USD 74.2 million in 2023 due to the crucial role of CBG minor cannabinoids in supporting health and wellness, particularly in areas such as pain management, inflammation reduction, and mood regulation.

The isolates product segment in the U.S. minor cannabinoids industry amassed 65% market share in 2023, on account of the growing consumer interest in minor cannabinoids for their potential health benefits.

Northeast zone minor cannabinoids industry accounted for 14.7% revenue share in 2023, led by the presence of prominent research institutions and medical centers in this region.